![Jung-Chool Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jung-Chool Kim
Amministratore Delegato presso
APROGEN BIOLOGICS INC.
Patrimonio netto: 108 158 $ in data 30/09/2026
Profilo
Jung-Chool Kim currently works at Aprogen Biologics, Inc., as Co-Chief Executive Officer & Director, AP Healthcare, Inc., as Chief Executive Officer & Director from 2022, N2TECH Co., Ltd., as Director & Head-Management from 2025, and E&M Revolution Co., Ltd., as Director.
Mr. Kim also formerly worked at Chunggei Pharm Co. Ltd., as Chief Executive Officer, Aprogen, Inc., as Director, Aprogen Biologics, Inc. (Korea), as Director, and Aprogen, Inc., as Director from 2017 to 2022.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
APROGEN, INC 0,29% | 23/09/2026 | 74.895 ( 0,29% ) | 106 574 $ | 30/09/2026 |
APROGEN BIOLOGICS 0,01% | 07/09/2026 | 1.458 ( 0,01% ) | 1 583 $ | 30/09/2026 |
Posizioni attive di Jung-Chool Kim
| Società | Posizione | Inizio |
|---|---|---|
| APROGEN BIOLOGICS INC. | Amministratore Delegato | 01/04/2012 |
| APTOCROM INC. | Amministratore Delegato | 23/03/2022 |
| N2TECH CO.,LTD | Direttore/Membro del Consiglio | 31/05/2025 |
E&M Revolution Co., Ltd.
 E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jung-Chool Kim
| Società | Posizione | Fine |
|---|---|---|
| APROGEN MEDICINES INC. | Direttore/Membro del Consiglio | 18/07/2022 |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Direttore/Membro del Consiglio | - |
Aprogen Biologics, Inc. (Korea)
 Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Engages in the production of bacterial and virus vaccines | Direttore/Membro del Consiglio | - |
Chunggei Pharm Co. Ltd.
 Chunggei Pharm Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medicine | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Aprogen, Inc.
 Aprogen, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines development and carbon steel distribution services | Health Technology |
Aprogen Biologics, Inc.
 Aprogen Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
AP Healthcare, Inc.
 AP Healthcare, Inc. Medical DistributorsDistribution Services Wholesales and retails drugs and publishes mobile games | Distribution Services |
Chunggei Pharm Co. Ltd.
Chunggei Pharm Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes medicine | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Engages in the production of bacterial and virus vaccines | Health Technology |
N2TECH Co., Ltd.
 N2TECH Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Manufactures hardware components for semiconductor equipment | Miscellaneous |
